financetom
Business
financetom
/
Business
/
Brandywine Realty Trust's Q3 FFO Falls, Revenue Rises; Trims 2024 FFO Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brandywine Realty Trust's Q3 FFO Falls, Revenue Rises; Trims 2024 FFO Guidance
Oct 23, 2024 1:44 AM

04:25 AM EDT, 10/23/2024 (MT Newswires) -- Brandywine Realty Trust ( BDN ) reported Q3 funds from operations late Tuesday of $0.23 per diluted share, down from $0.29 a year earlier.

Analysts polled by Capital IQ expected $0.24.

Revenue for the quarter ended Sept. 30 was $131.8 million, compared with $129.4 million a year earlier.

Four analysts surveyed by Capital IQ expected $124.2 million.

The company lowered its 2024 FFO guidance to now be between $0.89 and $0.92 per share, from the prior outlook of $0.91 to $0.96.

Analysts surveyed by Capital IQ expect $0.92.

Price: 6.17, Change: -0.10, Percent Change: -1.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Falcon Oil & Gas Completes Shenandoah SS-2H ST1 Stimulation in Australia
Falcon Oil & Gas Completes Shenandoah SS-2H ST1 Stimulation in Australia
Feb 7, 2025
07:07 AM EST, 02/07/2025 (MT Newswires) -- Falcon Oil & Gas ( FOLGF ) on Friday said it has completed the Shenandoah S2-2H ST1 stimulation in the Beetaloo Sub-basin in the Northern Territory, Australia, with joint venture partner Tamboran (B2) Pty. The companies successfully completed 35 stages across the 1,671-meter horizontal section of the Amungee Member B-shale with the Liberty...
Eton Pharmaceuticals Says US Patent Granted for ET-600 Formulation
Eton Pharmaceuticals Says US Patent Granted for ET-600 Formulation
Feb 7, 2025
07:07 AM EST, 02/07/2025 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) said Friday that the US Patent and Trademark Office has granted a patent for the formulation of its ET-600 product candidate, a desmopressin oral solution being developed as potential treatment for diabetes insipidus. The company said the patent expires in 2044 and is expected to be listed in...
Accenture scraps diversity and inclusion goals, FT reports
Accenture scraps diversity and inclusion goals, FT reports
Feb 7, 2025
Feb 7 (Reuters) - Accenture ( ACN ) has scrapped its global diversity and inclusion goals after an evaluation of the U.S. political landscape, the Financial Times reported on Friday, citing a memo to the company's staff from CEO Julie Sweet. (Reporting by Rishi Kant in Bengaluru; Editing by Devika Syamnath) ...
Alibaba exec says reports that it plans to invest in DeepSeek are untrue - The Paper
Alibaba exec says reports that it plans to invest in DeepSeek are untrue - The Paper
Feb 7, 2025
SHANGHAI, Feb 7 (Reuters) - An Alibaba executive has denied reports that the Chinese e-commerce giant intends to invest in DeepSeek, Chinese news outlet The Paper reported on Friday. The Paper cited a post that Yan Qiao, a vice president at Alibaba ( BABA ), made on her personal WeChat moments feed where she said as a fellow Chinese and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved